Yazar "Uzaslan, Esra" seçeneğine göre listele
Listeleniyor 1 - 3 / 3
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Demographic, clinical and management characteristics of newly diagnosed COPD patients in Turkey: A real-life study(DOVE MEDICAL PRESS LTD, 2020) Süerdem, Mecit; Günen, Hakan; Akyıldız, Levent; Çilli, Aykut; Özlü, Tevfik; Uzaslan, Esra; Abadoğlu, Öznur; Bayram, Hasan; Çımrın, Arif Hikmet; Gemicioğlu, Bilun; Mısırlıgil, ZeynepPurpose: In order to determine the clinical and sociodemographic characteristics of newly diagnosed treatment-naive asthma and COPD patients in Turkey, a multicenter study in 2012 was initiated. We aimed to investigate the characteristics and therapies of COPD patients in the original study in more detail. Patients and Methods: This nation-wide, multicentric, non-interventional, prospective, real-life observational cohort study was conducted in 122 centers. The newly diagnosed patients were not receiving any treatment before the recruitment. Their general characteristics, the combined GOLD 2011 COPD categories and exacerbation histories were noted. The patients were followed up with 3 voluntary visits for 1 year. Their adherence to the inhaled treatment according to GOLD 2011 was evaluated during follow-up visits. Results: The study included 776 COPD patients. Their mean age was 59.4 +/- 9.1 years, and 11.9% of the patients were female. 35.1% of the patientswere in the GOLD 2011 C and D category. 12.6% are frequent exacerbators, and 52.8% had at least one comorbid condition. 71.8% overtreatment rate was detected. Their attendance rates for three follow-up visits became 55.9%, 32.9% and 18.7%, respectively. The adherence rate to the treatment was measured as 81.9%. Conclusion: Although these patients were diagnosed for the first time, the GOLD C and D categories and frequent exacerbator phenotype were found at a high rate. They were usually prescribed an overtreatment regimen. We think that newly diagnosed COPD patients should be evaluated carefully, and best effort should be made to treat these patients in accordance with the recommendations of the major COPD guidelines.Öğe Epidemiology and distribution of interstitial lung diseases in Turkey(2014) Müsellim, Benan; Okumuş, Gülfer; Uzaslan, Esra; Akgün, Metin; Çetinkaya, Erdoğan; Turan, Onur; Akkoçlu, AtilaIntroduction: There is very few data on the epidemiological features of interstitial lung diseases (ILD) in the literature. These studies on this subject suffer from limited number of patients. Objective: The goal of this study was to evaluate the epidemiological features of ILD in Turkey. Methods: Fifty-four investigators, 31 centres in 19 cities from six regions of Turkey, participated in the study. Two thousand two hundred forty-five newly diagnosed patients (51.8% females), led by Turkish Thoracic Society Clinical Problems Study Group, enrolled in this prospective study. Results: The mean age was 51.8±16.7 years. The mean age among males was 50.5±18.6 years and 53.0±14.6 years among females (P<0.001). 23.8% of the cases had ILD with known causes, while 39.4% were in granulomatous group, 23.7% were idiopathic, and 4.4% were in the unclassified group. Overall, histopathologically confirmed diagnosis rate was 40.4%. Sarcoidosis was the most common disease (37%), whereas cases with idiopathic pulmonary fibrosis (IPF) constituted 19,9% of patients. 53% of the sarcoidosis patients were females, and the ratio reaches to 75% under 50 years of age (for this group, IPF ratio is %3). In contrast, sarcoidosis and IPF ratios were equal in males (25%). Sarcoidosis was 8% in men over 50, while IPF was %45. Conclusion: The overall incidence of ILD in Turkey was computed to be 25.8/100000. © 2013 John Wiley & Sons Ltd.Öğe Factors Affecting Control and Adherence to One Year Treatment in Elderly Asthmatics in Turkey(MOSBY-ELSEVIER, 2016) Gemicioğlu, Bilun; Bayram, Hasan; Çımrın, Arif; Abadoğlu, Öznur; Çilli, Aykut; Uzaslan, Esra; Günen, Hakan[Abstract not Available]
